OCU400
-
Malvern-Based Ocugen Secures Multimillion Dollar Licensing Deal with Korean Pharma Giant
Malvern-based biotech company Ocugen has signed a licensing deal for its experimental gene therapy with South Korea’s Kwangdong Pharmaceutical, writes John George for Philadelphia Business…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
